.png){kind=icon}
返回
Monocyte programming by cancer therapy
.png){kind=icon}
OA
AI
DOI：10.3389/fimmu.2022.994319.png)
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Monocytes in peripheral blood circulation are the precursor of essential cells that control tumor progression, that include tumor-associated macrophages (TAMs), dendritic cells (DCs) and myeloid-derive suppressor cells (MDSC). Monocytes-derived cells orchestrate immune reactions in tumor microenvironment that control disease outcome and efficiency of cancer therapy. Four major types of anti-cancer therapy, surgery, radiotherapy, chemotherapy, and most recent immunotherapy, affect tumor-associated macrophage (TAM) polarization and functions. TAMs can also decrease the efficiency of therapy in a tumor-specific way. Monocytes is a major source of TAMs, and are recruited to tumor mass from the blood circulation. However, the mechanisms of monocyte programming in circulation by different therapeutic onsets are only emerging. In our review, we present the state-of-the art about the effects of anti-cancer therapy on monocyte progenitors and their dedifferentiation, on the content of monocyte subpopulations and their transcriptional programs in the circulation, on their recruitment into tumor mass and their potential to give origin for TAMs in tumor-specific microenvironment. We have also summarized very limited available knowledge about genetics that can affect monocyte interaction with cancer therapy, and highlighted the perspectives for the therapeutic targeting of circulating monocytes in cancer patients. We summarized the knowledge about the mediators that affect monocytes fate in all four types of therapies, and we highlighted the perspectives for targeting monocytes to develop combined and minimally invasive anti-cancer therapeutic approaches.
Keyword:
monocyte
anti-cancer treatment
surgery
chemotherapy
radiotherapy
immunotherapy
genotype
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
5.9
论文数:
5.0W
被引数:
22.7W
机构
引用论文
Chemotherapy Induces Breast Cancer Stemness in Association with Dysregulated Monocytosis.png)
CLINICAL CANCER RESEARCHOAAI
CLINICAL CANCER RESEARCHIF10.2
OAAI分享收藏Tumor-Derived CCL2 Mediates Resistance to Radiotherapy in Pancreatic Ductal AdenocarcinomaCLINICAL CANCER RESEARCHOAAI
CLINICAL CANCER RESEARCHIF10.2
OAAI分享收藏分享收藏Immune checkpoints in targeted-immunotherapy of pancreatic cancer: New hope for clinical development胰腺癌靶向免疫治疗中的免疫检查点: 临床发展的新希望OAAI
OAAI分享收藏分享收藏
查看更多内容